Please join us for our annual conference offering legal insights into recent developments, challenges, and opportunities facing U.S. and multi-national health care providers, life sciences companies, and industry investors.

Referent: Gerard M. Donovan Christopher R. Brennan Brian Bewley Nicole J. Aiken-Shaban Kaitlyn L. Dunn Arielle R. Lusardi Joseph W. Metro Lesley C. Reynolds David A. Bender Michelle A. Mantine Natasha Tardif Vicki J. Tankle Wendell J. Bartnick Nancy Bonifant Halstead Scot T. Hasselman Sarah Thompson Schick Matthew K. Loughran Sarah Cummings Stewart Elizabeth C. Brandon Paul W. Pitts

Veranstaltungsart: Webinar, CLE / CPD

Startdatum / -uhrzeit:
17 March 2025, 10:30 AM EDT
Enddatum / -uhrzeit:
21 March 2025, 2:00 PM EDT

This year, the conference will be virtual, with CLE webinars offered throughout the week on important and timely topics for the industry.

Please log in 15 minutes prior to the start of the programs.

Safeguarding Medical Device IP Amid an Evolving “Right to Repair”

Monday, March 17th from 10:30am - 11:30am ET

Right to Repair advocates have successfully lobbied for access to information, including manufacturers’ intellectual property, for diagnostics, repair, and maintenance in several key states. The Library of Congress has recognized a three-year exemption from a federal anti-hacking law necessary for diagnosing, maintaining, and repairing medical devices. Third-party servicers are turning to federal and state antitrust laws to push back against companies that use access controls to ensure the safety and security of their products and protect their intellectual property.

Our presenters have litigated these issues across the country. Join them for a discussion regarding emerging risks and best practices for maximizing the value of medical device IP and aftermarket services.

Speakers: Gerard Donovan and Chris Brennan

Health Care Transactions: An Overview of Recent Developments and Predictions for What’s to Come

Monday, March 17th from 1pm - 2:30pm ET

This panel will discuss deal flow activity and developments in 2024. The presenters will also discuss predictions for the future given the administration change and shifting policy positions.

Please note: This session will qualify for 1.5 CLE credits in applicable jurisdictions.

Speakers: Brian Bewley, Nicole Aiken-Shaban, Katie Dunn and Arielle Lusardi

The 340B Program at a Crossroads

Tuesday, March 18th from 10am - 11am ET

This session will provide a brief overview of the 340B drug discount program, followed by an update on expanding program-related litigation affecting contract pharmacy and rebate models, state and federal legislative proposals affecting the program, and the interaction with other emerging federal drug price regulation programs under the Inflation Reduction Act.

Speaker: Joe Metro